BCL2L14 Antikörper (AA 298-312)
Kurzübersicht für BCL2L14 Antikörper (AA 298-312) (ABIN636238)
Target
Alle BCL2L14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 298-312
-
Aufreinigung
- Affinity chromatography purified
-
Immunogen
- Bcl-G antibody was raised in rabbit using AA 298-312 [TKYLKENFSPWIQQH] of the human BCL-G Long form protein as the immunogen.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- Lot specific
-
Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- BCL2L14 (BCL2-Like 14 (Apoptosis Facilitator) (BCL2L14))
-
Hintergrund
- Bcl-G is a novel pro-apoptotic member of the Bcl-2 family. The human BCL-G gene encodes two proteins through alternative mRNA splicing, Bcl-G(L) (long) and Bcl-G(S) (short) consisting of 327 and 252 amino acids in length, respectively. Bcl-G(L) mRNA is expressed widely in adult human tissues, whereas Bcl-G(S) mRNA was found only in testis. Overexpression of Bcl-G(L) or Bcl-G(S) in cells induced apoptosis although Bcl-G(S) was far more potent than Bcl-G(L).
Target
-